Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An Alzheimer's disease that is characterized by an associated with variation in the region 1q25.
Biomarker and diagnostic research for Alzheimer disease 14 has been reported in the published literature.
1 clinical trial registered. Interventions under study include medical devices. Pipeline includes 1 NA. Research is primarily industry-sponsored.
311 publications have been identified in PubMed for Alzheimer disease 14. Kisho has analyzed 190 by research type. Research spans Review / Meta-Analysis (33%), Basic Science / Preclinical (24%), and Epidemiology / Natural History (22%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 63 | 33% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:49 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about Alzheimer disease 14
Laboratory research |
45 |
24% |
Disease patterns and progression | 41 | 22% |
Testing and diagnosis research | 19 | 10% |
New treatment approaches | 9 | 5% |
Clinical study results | 8 | 4% |
Other research | 3 | 2% |
Patient case studies | 2 | 1% |
Wu CK (2026). [PMID: 41609117](https://pubmed.ncbi.nlm.nih.gov/41609117/). *Acta Neurol Taiwan*. [Review / Meta-Analysis]
He A (2026). [PMID: 41419665](https://pubmed.ncbi.nlm.nih.gov/41419665/). *Nat Aging*. [Gene Therapy / Novel Therapeutics]
Raket LL (2026). [PMID: 41178353](https://pubmed.ncbi.nlm.nih.gov/41178353/). *Brain*. [Diagnostic / Biomarker]
Banerjee G (2026). [PMID: 41910964](https://pubmed.ncbi.nlm.nih.gov/41910964/). *JAMA Neurol*. [Case Report / Case Series]
Madeline V (2026). [PMID: 41843743](https://pubmed.ncbi.nlm.nih.gov/41843743/). *Scand J Work Environ Health*. [Epidemiology / Natural History]
Niziński P (2026). [PMID: 41599368](https://pubmed.ncbi.nlm.nih.gov/41599368/). *Molecules*. [Review / Meta-Analysis]
Fu X (2026). [PMID: 41526986](https://pubmed.ncbi.nlm.nih.gov/41526986/). *Mol Neurodegener*. [Epidemiology / Natural History]
Hendrickx Van de Craen E (2026). [PMID: 41494406](https://pubmed.ncbi.nlm.nih.gov/41494406/). *Neurobiol Aging*. [Basic Science / Preclinical]
Sun D (2026). [PMID: 41763009](https://pubmed.ncbi.nlm.nih.gov/41763009/). *J Prev Alzheimers Dis*. [Epidemiology / Natural History]
Tsai HR (2026). [PMID: 41477735](https://pubmed.ncbi.nlm.nih.gov/41477735/). *Ophthalmol Retina*. [Epidemiology / Natural History]
AI-curated news mentioning Alzheimer disease 14
Updated Apr 17, 2026
speech based digital biomarkers for early etiological stratification of alzheimer s disease and frontotemporal degeneration a biomarker confirmed prospective study
mitochondrial dysfunction and programmed cell death in alzheimer s disease a retrospective bioinformatics study